PedAM
Pediatric Disease Annotations & Medicines
| Disease | myocardial infarction |
| Symptom | |diabetes |
| Sentences | 128 |
| PubMedID- 22761919 | Twenty-six percent had hypercholesterolemia, 6.1% diabetes, 1.9% a history of myocardial infarction. |
| PubMedID- 22182634 | However the prevalence of myocardial infarction was higher in patients with diabetes as a co-morbid condition, although this was possibly due to different age distribution. |
| PubMedID- 21238901 | Impact of diabetes on outcome in patients with non-st-elevation myocardial infarction. |
| PubMedID- 21386989 | Third, we further adjusted for systolic blood pressure, blood pressure lowering medication, total and hdl cholesterol, diabetes, history of myocardial infarction, history of congestive heart failure, serum potassium (continuous), and serum calcium (continuous). |
| PubMedID- 26115092 | In conclusion, this nationwide, population-based cohort study demonstrated that in type 2 diabetes patients with recent myocardial infarction, the use of sitagliptin is not associated with increased risk of composite adverse cardiovascular outcomes, including myocardial infarction, ischemic stroke, and cardiovascular death. |
| PubMedID- 24348585 | This is confirmed by the lack of any effect of glucose-insulin infusions in the acute phase of myocardial infarction in patients without diabetes (39). |
| PubMedID- 20700422 | Pioglitazone is associated with a lower risk of death, myocardial infarction, and stroke in patients with diabetes . |
| PubMedID- 23757599 | Previous studies have reported that cimt is increased in children at high risk for cardiovascular disease because of familial hypercholesterolemia, type 1 diabetes, having parents with premature myocardial infarction, or elevated levels of ultrasensitive c-reactive protein compared with other children (jarvisalo et al. |
| PubMedID- 24660315 | Objective: to evaluate if patient characteristics would have significant effects on outcomes for inpatients' myocardial infarction (mi) with type 2 diabetes (t2d) admitted to non-federal hospitals. |
| PubMedID- 24619127 | myocardial infarction) in persons with type 2 diabetes who are exposed to air pollution . |
| PubMedID- 20431807 | 30 type 2 diabetes mellitus cases with myocardial infarction and equal members of type 2 diabetics without complications are enrolled. |
| PubMedID- 24708579 | Pioglitazone also reduced the risk of hospitalization for acute myocardial infarction in patients with type 2 diabetes in comparison with rosiglitazone . |
| PubMedID- 19395095 | Aims: the presence of diabetes mellitus (dm) in patients with myocardial infarction (mi) increases mortality, due in part to the presence of known cardiovascular risk factors. |
| PubMedID- 23933608 | Age, killip class, diabetes mellitus, history of stroke and myocardial infarction were independent predictors of death. |
| PubMedID- 26279482 | Aims: to assess the risk of acute myocardial infarction (ami) in patients with type 2 diabetes mellitus treated with long-acting insulin analogues in comparison with other basal insulin therapy. |
| PubMedID- 23674307 | Our main objective was to evaluate the association between intensive statin therapy and new-onset diabetes mellitus in patients with myocardial infarction and to evaluate the association of intensive statin therapy with long-term adverse clinical outcomes. |
| PubMedID- 22247898 | The case fatality rate after myocardial infarction is higher in patients with diabetes than in patients without diabetes . |
| PubMedID- 20158090 | Thus, pioglitazone reduced the composite of all-cause mortality, non-fatal myocardial infarction, and stroke in patients with type 2 diabetes who have a high risk of macrovascular events. |
| PubMedID- 22247905 | diabetes with no history of myocardial infarction are equally at risk for myocardial infarction as are non-diabetic subjects with a history of myocardial infarction, and they are both classified in the same coronary artery disease risk group 4. |
| PubMedID- 24773097 | Incremental costs associated with myocardial infarction and stroke in patients with type 2 diabetes mellitus: an overview for economic modeling. |
| PubMedID- 20009093 | Objective to assess the ability to identify potential association(s) of diabetes medications with myocardial infarction using usual care clinical data obtained from the electronic medical record. |
| PubMedID- 22439599 | Reported that bezafibrate significantly decreased the combined incidence of ischemic change in ecg and documented myocardial infarction in patients with type 2 diabetes . |
| PubMedID- 22301118 | Association of coexisting diabetes and depression with mortality after myocardial infarction. |
| PubMedID- 21907990 | We investigated whether snp rs4788102, which captures the entire sh2b1 variability, is associated with coronary artery disease (cad) and/or myocardial infarction (mi) in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 23459575 | Prevalence, incidence, and implications of silent myocardial infarctions in patients with diabetes mellitus. |
| PubMedID- 20809989 | The aims of the present study were to assess a potential association between circulating levels of inflammatory markers and hyperglycaemia measured during an acute st-elevation myocardial infarction (stemi) in patients without known diabetes, and to determine whether circulating levels of inflammatory markers measured early after an acute stemi, were associated with the presence of abnormal glucose regulation classified by an oral glucose tolerance test (ogtt) at three-month follow-up in the same cohort. |
| PubMedID- 20205960 | Hospital admissions by acute myocardial infarction among subjects with or without diabetes for years 2001-2006. |
| PubMedID- 21709632 | Importantly, cardiovascular outcome studies further suggested that pioglitazone reduced all-cause mortality, myocardial infarction, and stroke in patients with type 2 diabetes . |
| PubMedID- 22837677 | The risk of myocardial infarction in patients with diabetes and no history of cardiac disease roughly equates the risk in non-diabetic patients with known cardiac diseases 5. |
| PubMedID- 21357366 | In addition, another recent prospective study conducted in spain found a hazard ratio of 0.33 for fatal or nonfatal myocardial infarction in individuals with type 2 diabetes compared with nondiabetic individuals with a prior myocardial infarction (11). |
| PubMedID- 20442057 | Residential proximity to environmental sources of persistent organic pollutants and first-time hospitalizations for myocardial infarction with comorbid diabetes mellitus: a 12-year population-based study. |
| PubMedID- 21539643 | Heart rate turbulence can predict cardiac mortality following myocardial infarction in patients with diabetes mellitus. |
| PubMedID- 21747831 | Exercise microvolt t-wave alternans identify sudden cardiac death risk and have been identified in the ecgs of postmyocardial infarction patients with diabetes . |
| PubMedID- 23117562 | We examined levels and trends in cardiovascular risk factors and drug treatment in myocardial infarction (mi) patients with and without diabetes: 4837 patients with mi, out of which 1014 had type 2 diabetes and 3823 had no diabetes. |
| PubMedID- 24095940 | Risk factors for cardiovascular diseases (hypertension, diabetes, dyslipidaemia, family history of myocardial infarction or sudden death), risk factors for infectious diseases and vaccination status, risk factors for cancers (family history of prostate, breast or colon cancer; adenomatosus polyposis and/or personal history of inflammatory bowel disease (for colon cancer) and history of numerous (>40) nevi for skin cancer).compliance with current national recommendations regarding management (prevention, detection and treatment) of these comorbidities. |
| PubMedID- 24552888 | In multivariable cox analyses adjusting for randomized treatment, age, sex, diabetes, history of heart failure, myocardial infarction, ischemic heart disease, stroke, peripheral vascular disease, smoking status, baseline body mass index, serum total and high-density lipoprotein cholesterol, creatinine, glucose, and urine albumin/creatinine ratio as standard risk factors, and for incident myocardial infarction, in-treatment heart rate, systolic and diastolic pressure, cornell product, and sokolow-lyon voltage lvh treated as time-varying covariables, black race remained associated with a 45% decreased risk of developing new af (hr = 0.55; 95% ci = 0.35-0.87; p = 0.01). |
| PubMedID- 23097721 | In the prospective pioglitazone clinical trial in macrovascular events (proactive) study, however, improved glycemic control with pioglitazone reduced the composite endpoint of all-cause mortality, nonfatal myocardial infarction, and stroke in patients with type-2 diabetes and atherosclerosis 6. |
| PubMedID- 22717317 | The rate of incident myocardial infarction in people with diabetes was substantially lower than for those with chronic kidney disease when defined by egfr of less than 45 ml/min per 1.73 m(2) and severely increased proteinuria (6.6 per 1000 person-years, 6.4-6.9 vs 12.4 per 1000 person-years, 9.7-15.9). |
| PubMedID- 23874021 | The first trial, the cardiovascular inflammation reduction trial (cirt), has been funded by the nhlbi and will evaluate whether low-dose methotrexate (target dose, 20 mg/wk) as compared to placebo will reduce major vascular events among a group of post-myocardial infarction patients with either diabetes or metabolic syndrome, groups known to have high risk on the basis of a persistent pro-inflammatory response. |
| PubMedID- 26410961 | Hyperleptinemia and its relationship with myocardial necrosis markers (creatine phosphokinase, creatine phosphokinase-mb, troponin) give reason to suggest the important role of leptin in the development of inflammatory process associated with myocardial infarction in patients with and without diabetes mellitus. |
| PubMedID- 25671950 | The objective of study was to determine the frequency of newly diagnosis diabetes presenting with acute myocardial infarction. |
| PubMedID- 22679279 | Relationship between angiotensin-converting enzyme gene insertion/deletion polymorphism, angiographically defined coronary artery disease and myocardial infarction in patients with type 2 diabetes mellitus. |
| PubMedID- 21760680 | Subjects experiencing scd were significantly more likely to have hypertension, diabetes and a history of myocardial infarction/coronary artery disease (p<0.01 for all). |
| PubMedID- 23651827 | Using a cox proportional hazard model, age, diabetes, history of stroke and myocardial infarction and vitamin e serum levels (hr 0.77; 95% ci: 0.67-0.89; p=0.001) independently predicted cardiovascular events. |
| PubMedID- 20484611 | Recent meta-analyses suggest an increased risk of acute myocardial infarction (ami) in patients with type 2 diabetes mellitus (t2dm) treated with rosiglitazone. |
| PubMedID- 20359353 | Older age, elevated body mass index, higher triglyceride levels, hypercholesterolemia, diabetes, history of myocardial infarction were associated with higher rates of statin use; elevated alkaline phosphatase levels and cmv igg seropositivity were associated with less statin use. |
| PubMedID- 26180535 | Studies were excluded if (1) animals; (2) review and case report; (3) study focused on specific cad population, for example, female cad patients, acute myocardial infarction, cad with diabetes, and so on (4) duplicate reports. |
| PubMedID- 22343257 | Background: the impact of diabetes in patients with acute myocardial infarction (ami) treated with primary percutaneous coronary intervention (pci) is unclear. |
| PubMedID- 24124429 | 3 notably, the risk of myocardial infarction (mi) in patients with type 2 diabetes with no previous history of coronary heart disease is similar to that among patients without diabetes who have already had mi. |
| PubMedID- 23226370 | Worse clinical outcomes in acute myocardial infarction patients with type 2 diabetes mellitus: relevance to impaired endothelial progenitor cells mobilization. |